NCT07524894 2026-04-15
SNIFF
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Phase 2 Not yet recruiting
Clinical Trials
8 trialsNCT07530224 2026-04-15
JAK Inhibitors for Solid Malignant Tumor Patients With Refractory Immune Checkpoint Inhibitors-related Dermatitis
Hangzhou Cancer Hospital
Phase 2 Not yet recruiting
NCT07526597 2026-04-13
STOP-CLL-DCT
UNC Lineberger Comprehensive Cancer Center
Phase 2 Not yet recruiting
NCT07406724 2026-02-12
HS-IT101 Injection Versus Chemotherapy in the Treatment of Advanced Melanoma
Qingdao Sino-Cell Biomedicine Co., Ltd.
Phase 2 Not yet recruiting
NCT07339553 2026-01-21
Clinical Study of EZH2 Inhibitor Combined With PARP Inhibitor in the Treatment of Patients With Advanced or Recurrent Epithelial Ovarian Cancer.
Peking University Third Hospital
Phase 2 Not yet recruiting
NCT07301424 2025-12-24
Subcutaneous Blinatumomab Plus Ponatinib for BCR-ABL+ B-ALL
University of Alberta
Phase 2 Not yet recruiting
NCT07239622 2025-11-20
Liposomal Irinotecan Combined With Sintilimab and Anlotinib in the Treatment of Recurrent or Persistent Ovarian Clear Cell Carcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 2 Not yet recruiting
NCT06781112 2025-01-17
A Phase II Study of TPF With PD-1 Inhibitor Induction Therapy for Locally Advanced Nasopharyngeal Carcinoma
Chengdu University of Traditional Chinese Medicine
Phase 2 Not yet recruiting